212 related articles for article (PubMed ID: 17074815)
1. Dual role of SnoN in mammalian tumorigenesis.
Zhu Q; Krakowski AR; Dunham EE; Wang L; Bandyopadhyay A; Berdeaux R; Martin GS; Sun L; Luo K
Mol Cell Biol; 2007 Jan; 27(1):324-39. PubMed ID: 17074815
[TBL] [Abstract][Full Text] [Related]
2. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
He J; Tegen SB; Krawitz AR; Martin GS; Luo K
J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
[TBL] [Abstract][Full Text] [Related]
3. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
Zhu Q; Pearson-White S; Luo K
Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
[TBL] [Abstract][Full Text] [Related]
4. Expression profiles of SnoN in normal and cancerous human tissues support its tumor suppressor role in human cancer.
Jahchan NS; Ouyang G; Luo K
PLoS One; 2013; 8(2):e55794. PubMed ID: 23418461
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation.
Le Scolan E; Zhu Q; Wang L; Bandyopadhyay A; Javelaud D; Mauviel A; Sun L; Luo K
Cancer Res; 2008 May; 68(9):3277-85. PubMed ID: 18451154
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta regulator SnoN modulates mammary gland branching morphogenesis, postlactational involution, and mammary tumorigenesis.
Jahchan NS; You YH; Muller WJ; Luo K
Cancer Res; 2010 May; 70(10):4204-13. PubMed ID: 20460516
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.
Krakowski AR; Laboureau J; Mauviel A; Bissell MJ; Luo K
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12437-42. PubMed ID: 16109768
[TBL] [Abstract][Full Text] [Related]
8. SnoN in mammalian development, function and diseases.
Jahchan NS; Luo K
Curr Opin Pharmacol; 2010 Dec; 10(6):670-5. PubMed ID: 20822955
[TBL] [Abstract][Full Text] [Related]
9. SnoN Antagonizes the Hippo Kinase Complex to Promote TAZ Signaling during Breast Carcinogenesis.
Zhu Q; Le Scolan E; Jahchan N; Ji X; Xu A; Luo K
Dev Cell; 2016 Jun; 37(5):399-412. PubMed ID: 27237790
[TBL] [Abstract][Full Text] [Related]
10. Ski and SnoN: negative regulators of TGF-beta signaling.
Luo K
Curr Opin Genet Dev; 2004 Feb; 14(1):65-70. PubMed ID: 15108807
[TBL] [Abstract][Full Text] [Related]
11. Oncogene and tumour suppressor: the two faces of SnoN.
Lamouille S; Derynck R
EMBO J; 2009 Nov; 28(22):3459-60. PubMed ID: 19920850
[TBL] [Abstract][Full Text] [Related]
12. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
Band AM; Laiho M
Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNON-SMAD4.
Tecalco-Cruz AC; Sosa-Garrocho M; Vázquez-Victorio G; Ortiz-García L; Domínguez-Hüttinger E; Macías-Silva M
J Biol Chem; 2012 Aug; 287(32):26764-76. PubMed ID: 22674574
[TBL] [Abstract][Full Text] [Related]
14. Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas.
Zhang F; Lundin M; Ristimäki A; Heikkilä P; Lundin J; Isola J; Joensuu H; Laiho M
Cancer Res; 2003 Aug; 63(16):5005-10. PubMed ID: 12941827
[TBL] [Abstract][Full Text] [Related]
15. Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression.
Javelaud D; van Kempen L; Alexaki VI; Le Scolan E; Luo K; Mauviel A
Mol Cancer; 2011 Jan; 10(1):2. PubMed ID: 21211030
[TBL] [Abstract][Full Text] [Related]
16. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
Edmiston JS; Yeudall WA; Chung TD; Lebman DA
Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
[TBL] [Abstract][Full Text] [Related]
17. SnoN signaling in proliferating cells and postmitotic neurons.
Bonni S; Bonni A
FEBS Lett; 2012 Jul; 586(14):1977-83. PubMed ID: 22710173
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts.
Jinnin M; Ihn H; Mimura Y; Asano Y; Tamaki K
Arthritis Rheum; 2007 May; 56(5):1694-705. PubMed ID: 17469184
[TBL] [Abstract][Full Text] [Related]
19. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN.
Stroschein SL; Bonni S; Wrana JL; Luo K
Genes Dev; 2001 Nov; 15(21):2822-36. PubMed ID: 11691834
[TBL] [Abstract][Full Text] [Related]
20. SnoN suppresses TGF-β-induced epithelial-mesenchymal transition and invasion of bladder cancer in a TIF1γ-dependent manner.
Yin X; Xu C; Zheng X; Yuan H; Liu M; Qiu Y; Chen J
Oncol Rep; 2016 Sep; 36(3):1535-41. PubMed ID: 27430247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
